Synpeptide Art Residency

Our Call for an Artist in Residence raised a lot of interest within the art-science community worldwide. Our jury panel had the difficult task of selecting from 80 applications from 29 countries.

A jury panel, composed of members of the BIOPROCESS LABORATORY, BIOFACTION as well as an independent art curator, has carefully reviewed all applications and interviewed a final shortlist. The exponential quality of the shortlisted applicants has led us to establish not one but two residency spaces.

We are thrilled to reveal the two selected artists, who we believe would most benefit from the residency based on their background and proposals entered:

Sarah Craske

(at Bioprocess Laboratory, ETH Zürich, Basel, in collaboration with Biofaction)

&

Eduardo Miranda

(at Wagner Lab, University Regensburg, in collaboration with Biofaction)

 


 

Print

Image credit (top and above) Vic Phillips

 

Print

Sarah Craske selected as Artist in Residence

at BIOPROCESS LABORATORY, Prof Sven Panke, ETH Zürich, Basel, Switzerlandin collaboration with BIOFACTION, Vienna

About

Sarah Craske is a British artist, working at the intersection of Art, Science & Technology. She is interested in exploring how the concept of knowledge & data, practice & space, language & method, equipment & materials transform through transdisciplinary working and is developing her own transdiscipline – Biological Hermeneutics.

Sarah was recently awarded the NOVA Award for her collaborative work with Dr Simon Park. Selected from 1300 artists. The work chosen “represents truly original creative thinking and execution, with an emphasis on craft, skill & exceptional accomplishment”.

 

 

 

sarahcraske-image

Biological Hermeneutics, Sarah Craske

 

The Residency

Sarah did her work in Basel with scientists and bioengineers of the ETH Zurich’s Bioprocess Laboratory. Throughout the process, Sarah spent her time working in the lab, researching about Basel’s history and constructing and editing her artwork. Since Basel has an extensive history with the chemical and pharmaceutical industries, Sarah’s research led her to the Basel Pharmacy Museum, where she gained many useful impressions for her work. She found out that cholera was one of the most significant bacterial epidemics in the history of Basel. Wishing to reflect this historical fact on her work, she looked for historic remedies for cholera and discovered medieval recipes that included garlic and an ancient panacea called Theriak. Sarah wondered whether she could combine these historic approaches with technologies and methods used by synthetic biology and decided to create her own synthetic peptide version of Theriak. As an outcome of her residence, she decided to inoculate a map of Basel with cholera, and then try to inhibit its outbreak by applying peptides, which she had designed with a special twist. Sarah’s aims were to create an artwork that plays on the cultural and aesthetic heritage used within science, disease and fighting bacterial infections, while demonstrating viable experiments that are both interesting from an art and scientific perspective.

 

We’re publishing a full report of both residencies shortly. Stay tuned!

 

News

  • Sarah published an initial report in the August 2017 edition of Interalia magazine.
  • The work will be exhibited in the Basel Pharmacy Museum, running from 16 October 2018 for 3 months. It will include amongst other things, the original synthesised THERIAK peptide, displayed alongside the original panacea within their cabinets and a projection of the disease map time-lapse within one of their dioramas.

 

More infos:
Sarah Craske
Bioprocess Laboratory

 


 

 

 

 

Print

Eduardo Miranda selected as Artist in Residence

at UNIVERSITY REGENSBURG, Prof Ralf Wagner, Germany in collaboration with BIOFACTION, Vienna

About

Eduardo Miranda is a composer and AI scientist working at the crossroads of biology & music for over 20 years. His artistic work and research contributes to the advancement of scientific knowledge on AI, Neuroscience and Bio-engineering.

As a composer his aim is to produce pieces of music that are as much as possible informed by science, rather than merely inspired by it. He has recently developed an interactive music system using an organic memristor, developed at Plymouth University.

 

 

 

Biocomputer Music, Eduardo Miranda

Biocomputer Music, Eduardo Miranda

 

The Residency

Eduardo worked with scientists in the University of Regensburg’s Wagner Lab. After spending time in the lab learning about the structure and function of naturally occurring lantibiotics and how new kinds might be engineered, Eduardo felt that the process of synthesising new proteins reminded him strongly of his own process of creating new pieces of music. This realisation inspired him to invent a new concept: Artificial Biology, or A-Biology, which is the surreal biology of a parallel universe of musical molecules. The A-Biology framework, a Turing machine inspired process, consists of a number of pieces of software that processes strands of DNA. After generating musical molecules with the A-Biology system, Eduardo edited these molecules into an experimental musical composition, ARTIBIOTICS, for percussion ensemble and electronics.

 

We’re publishing a full report of both residencies shortly. Stay tuned!

 

News

  • BBC 3 covered the works of Eduardo on the 9 December 2017.
  • Biofaction created a musical survey on which you can rate the musical strands from ARTIBIOTICS. The most highly rated ARTIBIOTIC will be unveiled at the premiere at Peninsula Arts Contemporary Music Festival.
  • Artibiotics will be premiered at the Gala Concert of the Peninsula Arts Contemporary Music Festival 2018, Plymouth, on 3 March 2018, by Ensemble Bash. The 2018 festival title is “Decoding Life”, and Biofaction’s Markus Schmidt will launch the festival with a lecture on 2 March 2018.

 

More infos:
Eduardo Miranda
Biocomputing Music and another clip here
Wagner Lab